Calidi Biotherapeutics, Inc. (CLDWW) Operating cash flow 2022–2025
Calidi Biotherapeutics, Inc. (CLDWW) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$21.3MFY2025 · since FY2022: -$13.2M → -$21.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$21.3M | -8.1% |
| FY2024 | -$19.7M | +27.0% |
| FY2023 | -$27.0M | -104.2% |
| FY2022 | -$13.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CLDWW financial trends
CLDWW RevenueCLDWW Net incomeCLDWW Net marginCLDWW Gross profitCLDWW Gross marginCLDWW Operating incomeCLDWW Operating marginCLDWW Free cash flowCLDWW Capital expendituresCLDWW Return on equityCLDWW Stock buybacksCLDWW Dividends paidCLDWW Total assetsCLDWW Total liabilitiesCLDWW Shareholders’ equityCLDWW overview →